Stenobird

Episode

Redefining CAR-T Timing and Patient Access with Allogene Therapeutics' Dr. Zachary Roberts

Podcast
Cell & Gene: The Podcast
Published
May 21, 2026
Duration seconds
1093
Processing state
not_requested
Canonical source
https://www.buzzsprout.com/1810482/episodes/19194678-redefining-car-t-timing-and-patient-access-with-allogene-therapeutics-dr-zachary-roberts.mp3
Audio
https://www.buzzsprout.com/1810482/episodes/19194678-redefining-car-t-timing-and-patient-access-with-allogene-therapeutics-dr-zachary-roberts.mp3
JSON
/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/redefining-car-t-timing-and-patient-access-with-allogene-therapeutics-dr-zachary-roberts
Markdown
/podcast/cell-gene-the-podcast-4048431/redefining-car-t-timing-and-patient-access-with-allogene-therapeutics-dr-zachary-roberts.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/redefining-car-t-timing-and-patient-access-with-allogene-therapeutics-dr-zachary-roberts/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/cell-gene-the-podcast-4048431/redefining-car-t-timing-and-patient-access-with-allogene-therapeutics-dr-zachary-roberts.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

We love to hear from our listeners. Send us a message. In episode 129 of Cell & Gene: The Podcast, Host Erin Harris reconnects with Zachary Roberts, M.D., Ph.D., EVP of Research & Development and Chief Medical Officer at Allogene Therapeutics, to explore how allogeneic CAR-T is evolving from a scalability promise into an earlier-line, potentially curative intervention. Their conversation centers on the ALPHA3 trial, where MRD-guided treatment is redefining when and how CAR-T can be de...